PUBLISHED DATE: 11-JAN-17

Zika Virus Vaccines Market

Opportunities and Forecasts,2014 – 2022

Zika virus belongs to Flavivirus, a genus of the viruses in the Flaviridae family, and it is transmitted via Aedes mosquito, blood transfusion, sex, and from an infected pregnant woman to her fetus.

The infection of this virus can cause adverse effects such as neurological problems and congenital birth defects in the fetus.

Zika virus is affecting people staying in Zika-infested regions and also the infection is linked with many babies being born with underdeveloped brains.

The outbreak of Zika virus infection in Latin American Countries, especially in Brazil, in last two years; its continuous spread in North America, Asia-Pacific, and Middle East & Africa

Multiple players are in process of vaccine development based on various techniques such as recombinant, live attenuated, whole inactivated, nucleic acids, and viral vectors.

LAMEA showed the highest growth rate, accounting for major share in 2015, and is projected to continue this trend. Currently, nearly more than 22 countries of Latin America have reported active Zika virus infection.

ZIKA VIRUS VACCINES MARKET- INTRODUCTION

ZIKA VIRUS VACCINES MARKET- KEY FINDINGS

LAMEA accounted for approximately half of the share of the global market in 2015, and is projected to grow at a CAGR of 5.0%.

Asia-Pacific is the second largest potential market, and is expected to grow at a CAGR of 5.6%

Brazil has the highest potential and projected to grow at a CAGR of 7.2% during the forecast period in rapid adoption scenario.

TABLE OF CONTENTS

INTRODUCTION

EXECUTIVE SUMMARY

MARKET OVERVIEW

FORECAST SCENARIO ANALYSIS OF ZIKA VIRUS

VACCINES

POTENTIAL ANALYSIS OF ZIKA VIRUS VACCINE MARKET,

BY GEOGRAPHY

COMPANY PROFILES

GLOBAL POTENTIAL ANALYSIS OF ZIKA VIRUS VACCINES MARKET SEGMENTATION

TOP INVESTMENT POCKETS

THAILAND: POTENTIAL MARKET FOR ZIKA VIRUS VACCINES ($MILLION), (2017-2022)

ZIKA VIRUS VACCINES MARKET- BY GEOGRAPHY

North America, Europe, Asia Pacific, LAMEA

1) Takeda Pharmaceutical Co. Ltd

2) Bharat Biotech International Ltd

3) NewLink Genetics Co

4) Inovio Pharmaceuticals

5) GeneOne Life Science

6) GlaxoSmithKline plc

7) Sanofi S.A.

COMPANY PROFILES

THANK YOU

Follow Us On

Thank You!For More Details

Visit us at https://www.alliedmarketresearch.com/zika-virus-

vaccines-market